Chimeric antigen receptor (CAR) T-cell and T-cell receptor (TCR) T-cell therapies are promising treatments for a range of cancers, offering hope to patients whose cancers have become refractory to ...
Chimeric antigen receptor (CAR) T cells offer tremendous potential for cancer immunotherapy. These T cells express custom engineered T cell receptors (TCRs), allowing them to detect and attack cancer ...
Ajai Chari, MD, University of California San Francisco, explores the challenges that accompany integrating chimeric antigen receptor (CAR) T-cell therapies into multiple myeloma treatment. The advent ...
Adoptive therapies based on CAR/TCR T cells—that is, T cells with an engineered chimeric antigen receptor (CAR) or a T-cell receptor (TCR)—have shown promise for a range of cancers, offering hope to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results